A detailed history of Jefferies Group LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Jefferies Group LLC holds 105,566 shares of IONS stock, worth $4.31 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
105,566
Holding current value
$4.31 Million
% of portfolio
0.05%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Sep 21, 2023

BUY
$36.54 - $48.66 $2.25 Million - $3 Million
61,566 Added 139.92%
105,566 $4.67 Million
Q3 2022

Nov 14, 2022

BUY
$36.54 - $48.66 $3.86 Million - $5.14 Million
105,566 New
105,566 $4.67 Million
Q1 2022

May 16, 2022

SELL
$29.88 - $37.04 $1.31 Million - $1.63 Million
-44,000 Closed
0 $0
Q4 2021

Sep 21, 2023

SELL
$25.61 - $35.1 $3,508 - $4,808
-137 Reduced 0.31%
44,000 $1.34 Million
Q4 2021

Feb 14, 2022

SELL
$25.61 - $35.1 $7,017 - $9,617
-274 Reduced 0.62%
44,000 $1.34 Million
Q3 2021

Sep 21, 2023

SELL
$33.54 - $40.55 $756,897 - $915,091
-22,567 Reduced 33.83%
44,137 $1.48 Million
Q3 2021

Dec 17, 2021

SELL
$33.54 - $40.55 $2.23 Million - $2.7 Million
-66,567 Reduced 60.06%
44,274 $1.49 Million
Q3 2021

Nov 15, 2021

SELL
$33.54 - $40.55 $756,897 - $915,091
-22,567 Reduced 16.92%
110,841 $3.72 Million
Q2 2021

Sep 21, 2023

BUY
$34.54 - $47.25 $1.61 Million - $2.2 Million
46,577 Added 231.42%
66,704 $2.66 Million
Q2 2021

Aug 16, 2021

BUY
$34.54 - $47.25 $3.91 Million - $5.35 Million
113,281 Added 562.83%
133,408 $5.32 Million
Q1 2021

Sep 21, 2023

BUY
$42.51 - $63.78 $6,419 - $9,630
151 Added 0.76%
20,127 $904,000
Q1 2021

May 14, 2021

BUY
$42.51 - $63.78 $6,419 - $9,630
151 Added 0.76%
20,127 $905,000
Q4 2020

Sep 21, 2023

SELL
$45.3 - $60.27 $3.88 Million - $5.16 Million
-85,590 Reduced 81.08%
19,976 $1.13 Million
Q4 2020

Feb 16, 2021

BUY
$45.3 - $60.27 $904,912 - $1.2 Million
19,976 New
19,976 $1.13 Million
Q1 2020

May 15, 2020

SELL
$41.6 - $63.4 $342,076 - $521,338
-8,223 Closed
0 $0
Q4 2019

Feb 13, 2020

SELL
$53.85 - $65.27 $1.2 Million - $1.45 Million
-22,269 Reduced 73.03%
8,223 $497,000
Q3 2019

Nov 13, 2019

BUY
$59.06 - $72.15 $752,660 - $919,479
12,744 Added 71.81%
30,492 $1.83 Million
Q2 2019

Aug 14, 2019

SELL
$62.09 - $86.14 $139,826 - $193,987
-2,252 Reduced 11.26%
17,748 $1.14 Million
Q1 2019

May 15, 2019

BUY
$52.92 - $81.17 $182,997 - $280,685
3,458 Added 20.9%
20,000 $1.62 Million
Q4 2018

Feb 14, 2019

BUY
$43.37 - $59.54 $539,609 - $740,796
12,442 Added 303.46%
16,542 $894,000
Q3 2018

Nov 14, 2018

SELL
$42.88 - $53.7 $834,401 - $1.04 Million
-19,459 Reduced 82.6%
4,100 $211,000
Q2 2018

Aug 14, 2018

BUY
$40.53 - $50.7 $954,846 - $1.19 Million
23,559 New
23,559 $982,000
Q4 2017

Feb 14, 2018

SELL
$50.3 - $64.39 $609,434 - $780,149
-12,116 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$45.56 - $59.57 $552,004 - $721,750
12,116
12,116 $614,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.8B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.